会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Reagent, method and apparatus for measuring amylase activity
    • 用于测量淀粉酶活性的试剂,方法和仪器
    • US07183069B2
    • 2007-02-27
    • US10383007
    • 2003-03-06
    • Masaki YamaguchiHiroshi YoshidaNobutaka KusabaYasufumi Mizuno
    • Masaki YamaguchiHiroshi YoshidaNobutaka KusabaYasufumi Mizuno
    • C12Q1/40
    • G01N33/52C12Q1/40
    • An object of the present invention is to provide a means for measuring amylase activity existing in biological samples such as saliva in a more convenient manner and is particularly to provide a means (reagent for measurement, method for measurement and apparatus) by which a sample containing high concentrations of amylase is measured. There has been found a means (reagent for measurement, method for measurement and apparatus), whereby amylase activity in an amylase sample having a high activity value can be quite conveniently measured by making an oligosaccharide substrate carry on a support in an enzymatic method for measuring amylase activity using a modified oligosacharide substrate, whereupon the present invention has been achieved.
    • 本发明的目的是提供一种用于以更方便的方式测量存在于生物样品例如唾液中的淀粉酶活性的方法,并且特别地提供一种用于测量的装置(测量方法,测量方法和装置),通过该装置 测量高浓度的淀粉酶。 已经发现了一种方法(用于测量的试剂,测量方法和装置),其中具有高活性值的淀粉酶样品中的淀粉酶活性可以通过使寡糖底物在酶法测量中进行支持而非常方便地测量 使用改性的寡糖基底的淀粉酶活性,从而实现了本发明。
    • 2. 发明授权
    • Reagent and method for measuring amylase
    • 试剂和测定淀粉酶的方法
    • US07186696B2
    • 2007-03-06
    • US10379094
    • 2003-03-04
    • Masaki YamaguchiHiroshi YoshidaNobutaka Kusaba
    • Masaki YamaguchiHiroshi YoshidaNobutaka Kusaba
    • A01N43/04
    • C12Q1/40C12Q1/54
    • An object of the present invention is to provide a means for the measurement of amylase activity that exists in a biological sample such as saliva in a more convenient manner and particularly to provide a means (method and reagent) where a sample containing amylase in high concentration is directly measured without dilution. In the present invention, there has been found a method, which is an enzymatic method using a modified oligosaccharide substrate, comprising adding saccharide such as oligosaccharide that is competitive to the oligosaccharide substrate whereupon amylase activity in an amylase sample having a high activity value can be directly measured without dilution, and a result, the present invention has been achieved.
    • 本发明的目的是提供一种用于以更方便的方式测定存在于生物样品如唾液中的淀粉酶活性的方法,特别是提供一种方法(方法和试剂),其中含有高浓度淀粉酶的样品 直接测量而不稀释。 在本发明中,已经发现了使用改性的寡糖底物的酶法,其包括向寡糖底物添加竞争性低聚糖等糖类,由此具有高活性值的淀粉酶样品中的淀粉酶活性可以是 不经稀释直接测量,结果,本发明已经实现。
    • 3. 发明授权
    • Method for anticipating sensitivity to medicine for osteoporosis
    • 预测骨质疏松症药物敏感度的方法
    • US06566064B1
    • 2003-05-20
    • US09572891
    • 2000-05-18
    • Masataka ShirakiYasuyoshi OuchiTakayuki HosoiNobutaka KusabaToshiaki BabaHiroshi Yoshida
    • Masataka ShirakiYasuyoshi OuchiTakayuki HosoiNobutaka KusabaToshiaki BabaHiroshi Yoshida
    • C12Q168
    • C12Q1/6883C12Q2600/106C12Q2600/156
    • A method for anticipating sensitivity to a medicine for osteoporosis is provided which is characterized by analyzing respective genetic polymorphisms of a vitamin D receptor gene, an estrogen receptor gene, and an apolipoprotein E gene from a genome DNA contained in a sample obtained from a human, and anticipating, based on the analyzed combination of the genetic polymorphisms, that the sample is derived from an individual who shows a specific priority to sensitivities to a plurality of remedies for osteoporosis. A reagent for simultaneously detecting genetic polymorphisms is also provided which contains amplification primers and/or detection probes specific to respective genes of the vitamin D receptor gene, apolipoprotein E gene, and estrogen receptor gene. Further, a method for simultaneously detecting these genes, and a method for selecting remedies for bone disease based on the genetic polymorphisms are provided. According to the method of the present invention, a diagnosis as to which remedy, or medicine, for osteoporosis a subject patient has higher sensitivity can be made before the administration of the medicine so that selection of an appropriate medicine is possible and the QOL (quality of life) of the patient can be improved.
    • 本发明提供一种用于预测对于骨质疏松症药物的敏感性的方法,其特征在于分析来自人获得的样品中含有的基因组DNA中的维生素D受体基因,雌激素受体基因和载脂蛋白E基因的遗传多态性, 并且基于所分析的遗传多态性的组合,预期样品来源于对多种骨质疏松症的治疗方案具有特定优先权的个体。 还提供了用于同时检测遗传多态性的试剂,其包含对维生素D受体基因,载脂蛋白E基因和雌激素受体基因的各自基因特异的扩增引物和/或检测探针。 此外,提供了同时检测这些基因的方法,以及基于遗传多态性选择骨疾病补救方法。 根据本发明的方法,可以在给药之前进行对患者具有较高敏感性的骨质疏松症的补救或药物的诊断,以便选择合适的药物是可行的,并且生活质量 的生命)可以改善。
    • 8. 发明授权
    • Transmission system, transmission device, and clock synchronization method
    • 传输系统,传输设备和时钟同步方法
    • US08867681B2
    • 2014-10-21
    • US13248215
    • 2011-09-29
    • Hiroshi Yoshida
    • Hiroshi Yoshida
    • H04L7/00G06F1/12H04J3/06
    • G06F1/12H04J3/0685
    • A transmission system which couples a plurality of transmission devices to a control device includes a first transmission device which is one of the plurality of transmission devices; a first calculation circuit which calculates a first difference value indicating a frequency difference value between a common clock supplied from the control device and a first clock as a clock used in the first transmission device; and a transmitter which reports the first difference value to a second transmission device other than the first transmission device, wherein the second transmission device comprises: a second calculation circuit which calculates a second difference value indicating a frequency difference value between the common clock and a second clock used in the second transmission device, and a frequency controller which controls an oscillator generating the second clock so that the second difference value approaches the first difference value reported from the first transmission device.
    • 将多个传输设备耦合到控制设备的传输系统包括作为多个传输设备之一的第一传输设备; 第一计算电路,其计算指示从所述控制装置提供的公共时钟与所述第一时钟之间的频率差值作为所述第一发送装置中使用的时钟的第一差值; 以及向所述第一发送装置以外的第二发送装置报告所述第一差分值的发送机,其中,所述第二发送装置包括:第二计算电路,其计算表示所述公共时钟与第二发送装置之间的频率差值的第二差分值 在第二发送装置中使用的时钟,以及频率控制器,其控制产生第二时钟的振荡器,使得第二差值接近从第一发送装置报告的第一差值。